Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000128

Director sold 2,253 shares at $33.22 ($74,845)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krognes Steve E. Director 2022-08-19 Sale −2,253 $33.22 $74,845 149,468 D
Open-market sales · 2,253 sh · avg $33.22 · $74,845
Loading xslF345X03/wf-form4_166128765076444.xml…